SCHEMBL21855432

SCHEMBL21855432

O=C(O)CCn1ccccc1=O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PSMB1 P20618 1/20 0.62
ESR1 P03372 1/20 0.50
PARP1 P09874 1/20 0.50
MAPT P10636 2/20 0.49
EGLN3 Q9H6Z9 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 1/20 0.46
FABP3 P05413 1/20 0.46
FABP4 P15090 1/20 0.46
FABP5 Q01469 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
TSHR P16473 1/20 0.45
APEX1 P27695 1/20 0.44
CREBBP Q92793 1/20 0.44
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6047270 0.83 PSMB1 (0.56) PSMB1PARP1LMNAL3MBTL1TSHR
SCHEMBL9752595 0.81 L3MBTL1 (0.55) PSMB1LMNAL3MBTL1TSHRPOLB
SCHEMBL1280773 0.80 TSHR (0.56) PSMB1MAPTMEN1KMT2ALMNA
SCHEMBL9342969 0.78 PSMB1 (0.50) PSMB1LMNAL3MBTL1TSHRPOLB
SCHEMBL1724271 0.78 PSMB1 (0.50) PSMB1LMNAL3MBTL1TSHRPOLB
SCHEMBL9394796 0.77 L3MBTL1 (0.51) PSMB1LMNAL3MBTL1TSHRPOLB
SCHEMBL9752675 0.77 L3MBTL1 (0.51) PSMB1LMNAL3MBTL1TSHRPOLB
SCHEMBL15675117 0.77 PSMB1 (0.57) PSMB1MAPTMEN1KMT2ALMNA
Hydrochloric Acid SCHEMBL31491305 0.76 PSMB1 (0.49) PSMB1LMNAL3MBTL1TSHRPOLB
SCHEMBL9752719 0.75 L3MBTL1 (0.50) PSMB1LMNAL3MBTL1TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081299-B1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES UCB Biopharma SRL (BE) 2024-09-25 EP disclosed
US-20230192646-A1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES UCB Biopharma SRL (BE) 2023-06-22 US disclosed
WO-2020081581-A1 CHEMILUMINESCENT AND FLUORESCENT NANOPARTICLE FOR OPTICAL IMAGING OF CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2020-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192646-A1 DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES FCER2, FCGR2A, FCGR1A PSMB1 1505/4885ESR1 2224/4885PARP1 2286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.